Adventa Bhd (XKLS:7191) EBIT: RM-5.31 Mil (TTM As of Mar. 2026)


XKLS:7191 Adventa Bhd XKLS:7191
36 GF Score
Price RM0.13
GF Value RM0.24
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adventa Bhd EBIT?

Adventa Bhd XKLS:7191 36 EBIT is RM-5.31 Mil as of Mar. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 36/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review.

Adventa Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM-1.66 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM-5.31 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Adventa Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was -8.09%. Adventa Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -8.51%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Adventa Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -9.33%.

Adventa Bhd  (XKLS:7191) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Adventa Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-7.732 * ( 1 - 0% )/( (96.986 + 94.277)/ 2 )
=-7.732/95.6315
=-8.09 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=111.142 - 4.007 - ( 10.149 - max(0, 10.777 - 49.643+10.149))
=96.986

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=103.974 - 2.439 - ( 7.258 - max(0, 6.546 - 42.939+7.258))
=94.277

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Adventa Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-6.644/( ( (49.179 + max(27.918, 0)) + (48.791 + max(30.275, 0)) )/ 2 )
=-6.644/( ( 77.097 + 79.066 )/ 2 )
=-6.644/78.0815
=-8.51 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(14.338 + 15.726 + 4.753) - (4.007 + 0 + 2.892)
=27.918

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(13.643 + 15.852 + 3.219) - (2.439 + 0 + 0)
=30.275

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Adventa Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-5.306/56.866
=-9.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adventa Bhd EBIT Related Terms

Adventa Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Adventa Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adventa Bhd EBIT Chart

Adventa Bhd Annual Data
Trend Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.70 -4.60 -9.62 2.63 -3.97

Adventa Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.60 0.31 -4.56 -1.66

XKLS:7191 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Adventa Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adventa Bhd EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's EV-to-EBIT falls into.


XKLS:7191
36GF Score
Adventa Bhd XKLS:7191
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adventa Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-5.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM-5.31 Mil mean?
Adventa Bhd (XKLS:7191) has a EBIT of RM-5.31 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Adventa Bhd.
Is Adventa Bhd's EBIT too high?
Adventa Bhd's current EBIT is RM-5.31 Mil. Overall, Adventa Bhd has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's EBIT compare to ISRG and BDX?
Adventa Bhd's EBIT of RM-5.31 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Adventa Bhd. Adventa Bhd's current EBIT is RM-5.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 45.8% below its estimated fair value. The current EBIT is RM-5.31 Mil. Adventa Bhd's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current EBIT is RM-5.31 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adventa Bhd (XKLS:7191) Overvalued in 2026?

Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued. The current stock price of RM0.13 is trading 45.8% below its estimated GF Value™ of RM0.24. GuruFocus considers Adventa Bhd to be Possible Value Trap.

Key valuation signals for XKLS:7191:

  • EBIT: RM-5.31 Mil
  • GF Value™: RM0.24 vs. price of RM0.13 (45.8% below fair value)
  • GF Score™: 36/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adventa Bhd Business Description

Address No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
36GF Score

Get the complete analysis for XKLS:7191

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.13
Price
RM0.24
GF Value